MENU
+Compare
SGMO
Stock ticker: NASDAQ
AS OF
Jul 21 closing price
Price
$0.49
Change
-$0.02 (-3.92%)
Capitalization
121.38M

SGMO Sangamo Therapeutics Forecast, Technical & Fundamental Analysis

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases... Show more

Industry: #Biotechnology
SGMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SGMO with price predictions
Jul 18, 2025

SGMO sees MACD Histogram just turned negative

SGMO saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on July 14, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 42 instances where the indicator turned negative. In of the 42 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 10, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SGMO as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SGMO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SGMO broke above its upper Bollinger Band on June 25, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SGMO advanced for three days, in of 232 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. SGMO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (24.752) is normal, around the industry mean (18.143). P/E Ratio (0.000) is within average values for comparable stocks, (58.647). SGMO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.460). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (1.642) is also within normal values, averaging (270.975).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SGMO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
SGMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

SGMO is expected to report earnings to fall 88.71% to -1 cents per share on August 12

Sangamo Therapeutics SGMO Stock Earnings Reports
Q2'25
Est.
$-0.02
Q1'25
Missed
by $0.05
Q4'24
Missed
by $0.01
Q3'24
Beat
by $0.06
Q2'24
Missed
by $0.03
The last earnings report on May 12 showed earnings per share of -14 cents, missing the estimate of -9 cents. With 3.82M shares outstanding, the current market capitalization sits at 121.38M.
A.I. Advisor
published General Information

General Information

a developer of transcription factors in the regulation of genes

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
501 Canal Boulevard
Phone
+1 510 970-6000
Employees
405
Web
https://www.sangamo.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FSEN14.00N/A
N/A
FS Energy & Power Fund
BKFKF46.68N/A
N/A
Bakkafrost PF
HOKCF0.84N/A
N/A
Hong Kong & China Gas Co., Ltd.
VRDR0.09-0.01
-5.88%
Verde Resources, Inc.
RSRV160.25-14.75
-8.43%
Reserve Petroleum Company (The)

SGMO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SGMO has been loosely correlated with XNCR. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if SGMO jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGMO
1D Price
Change %
SGMO100%
+5.65%
XNCR - SGMO
36%
Loosely correlated
-1.10%
XENE - SGMO
35%
Loosely correlated
N/A
AMLX - SGMO
31%
Poorly correlated
+0.72%
TGTX - SGMO
30%
Poorly correlated
-3.27%
OCGN - SGMO
30%
Poorly correlated
+2.00%
More